1. Sakiko Harada, Miki Ando, Jun Ando, Midori Ishii, Tomoyuki Yamaguchi, Satoshi Yamazaki, Tokuko Toyota, Kazuo Ohara, Manami Ohtaka, Mahito Nakanishi, Chansu Shin, Chihaya Imai, Yozo Nakazawa, Hiromitsu Nakauchi and Norio Komatsu (2022). Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphomas. Molecular Therapy, 30(2), 534-549. doi: 10.1016/j.ymthe.2021.10.006.
2. Zhi Zhou, Sho Yoshimatsu, Emi Qian, Mitsuru Ishikawa, Tsukika Sato, Manami Ohtaka, Mahito Nakanishi and Hideyuki Okano (2021). Generation of a control human induced pluripotent stem cell line using the defective and persistent Sendai virus vector system. Stem Cell Research, 56, 102549. doi: 10.1016/j.scr.2021.102549.
3. Mari Ohira, Emika Kikuchi, Shiori Mizuta, Naomi Yoshida, Masafumi Onodera, Mahito Nakanishi, Torayuki Okuyama and Ryuichi Mashima (2021). Production of therapeutic iduronate-2-sulfatase enzyme with a novel single-stranded RNA virus vector. Genes to Cells, 26(11), 891-904. doi: 10.1111/gtc.12894.
4. Midori Ishii, Jun Ando, Satoshi Yamazaki, Tokuko Toyota, Kazuo Ohara, Yoshiki Furukawa, Yoshiyuki Suehara, Mahito Nakanishi, Kazutaka Nakashima, Koichi Ohshima, Hiromitsu Nakauchi and Miki Ando (2021). iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma. Cancer Immunology Research, 9(10), 1175-1186. doi: 10.1158/2326-6066.CIR-21-0193.
5. Hisaya Kato, Yoshiro Maezawa, Yasuo Ouchi, Naoya Takayama, Masamitsu Sone, Kanako Sone, Aki Takada-Watanabe, Kyoko Tsujimura, Masaya Koshizaka, Sayaka Nagasawa, Hisako Saitoh, Manami Ohtaka, Mahito Nakanishi, Hidetoshi Tahara, Akira Shimamoto, Atsushi Iwama, Koji Eto and Koutaro Yokote (2021). Generation of disease-specific and CRISPR/Cas9-mediated gene-corrected iPS cells from a patient with adult progeria Werner syndrome. Stem Cell Research, 53, 102360. doi: 10.1016/j.scr.2021.102360.
6. Kazuto Kimura, Masaya Tsukamoto, Takumi Yoshida, Miyuu Tanaka, Mitsuru Kuwamura, Manami Ohtaka, Ken Nishimura, Mahito Nakanishi, Kikuya Sugiura and Shingo Hatoya (2021). Canine induced pluripotent stem cell maintenance under feeder-free and chemically-defined conditions. Molecular Reproduction & Development, 88(6), 395-404. doi: 10.1002/mrd.23478.